Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

High expression of leucine zipper-EF-hand containing transmembrane protein 1 predicts poor prognosis in head and neck squamous cell carcinoma.

Chen L, Yang Y, Liu S, Piao L, Zhang Y, Lin Z, Li Z.

Biomed Res Int. 2014;2014:850316. doi: 10.1155/2014/850316. Epub 2014 Feb 5.

2.

Clinical implication of leucine zipper/EF hand-containing transmembrane-1 overexpression in the prognosis of triple-negative breast cancer.

Wang CA, Liu Q, Chen Y, Liu S, Xu J, Cui X, Zhang Y, Piao L.

Exp Mol Pathol. 2015 Apr;98(2):254-9. doi: 10.1016/j.yexmp.2014.12.012. Epub 2015 Jan 21.

PMID:
25617527
3.

LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.

Li N, Zheng Y, Xuan C, Lin Z, Piao L, Liu S.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):12893-900. eCollection 2015.

4.

Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.

Wang S, Li S, Yang X, Yang S, Liu S, Liu B, Liu J.

Eur J Cancer. 2014 Jan;50(2):379-87. doi: 10.1016/j.ejca.2013.10.003. Epub 2013 Nov 1.

PMID:
24189000
5.

Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).

Pectasides E, Rampias T, Sasaki C, Perisanidis C, Kouloulias V, Burtness B, Zaramboukas T, Rimm D, Fountzilas G, Psyrri A.

PLoS One. 2014 Apr 10;9(4):e94273. doi: 10.1371/journal.pone.0094273. eCollection 2014.

6.

[Prognostic significance of NADPH quinine oxidoreductase 1 overexpression in head and neck squamous cell carcinoma].

Yang Y, Jin T, Liu S, Chen L, Lin L, Han H, Li L, Lin Z.

Zhonghua Bing Li Xue Za Zhi. 2014 Jul;43(7):463-7. Chinese.

PMID:
25327796
7.

FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck.

Pattje WJ, Melchers LJ, Slagter-Menkema L, Mastik MF, Schrijvers ML, Gibcus JH, Kluin PM, Hoegen-Chouvalova O, van der Laan BF, Roodenburg JL, van der Wal JE, Schuuring E, Langendijk JA.

Histopathology. 2013 Aug;63(2):263-70. doi: 10.1111/his.12174. Epub 2013 Jun 13.

PMID:
23763459
8.

Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer.

Aigelsreiter AM, Aigelsreiter A, Wehrschuetz M, Ress AL, Koller K, Salzwimmer M, Gerger A, Schauer S, Bauernhofer T, Pichler M.

Hum Pathol. 2014 Apr;45(4):683-90. doi: 10.1016/j.humpath.2013.11.014. Epub 2013 Dec 2.

PMID:
24565202
10.

The expression of activin receptor-like kinase 1 among patients with head and neck cancer.

Chien CY, Chuang HC, Chen CH, Fang FM, Chen WC, Huang CC, Huang HY.

Otolaryngol Head Neck Surg. 2013 Jun;148(6):965-73. doi: 10.1177/0194599813479556. Epub 2013 Feb 27.

PMID:
23447486
11.

Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.

Menéndez ST, Rodrigo JP, Allonca E, García-Carracedo D, Alvarez-Alija G, Casado-Zapico S, Fresno MF, Rodríguez C, Suárez C, García-Pedrero JM.

J Pathol. 2010 Aug;221(4):402-10. doi: 10.1002/path.2722.

PMID:
20593490
12.

c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.

Baschnagel AM, Williams L, Hanna A, Chen PY, Krauss DJ, Pruetz BL, Akervall J, Wilson GD.

Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):701-7. doi: 10.1016/j.ijrobp.2013.11.013.

PMID:
24521684
13.

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.

Lin L, Piao J, Gao W, Piao Y, Jin G, Ma Y, Li J, Lin Z.

BMC Cancer. 2013 Jul 31;13:366. doi: 10.1186/1471-2407-13-366.

14.

Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.

Li G, Ren S, Su Z, Liu C, Deng T, Huang D, Tian Y, Qiu Y, Liu Y.

Tumour Biol. 2015 May;36(5):3949-56. doi: 10.1007/s13277-015-3038-6. Epub 2015 Jan 13.

15.

Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma.

Takikita M, Xie R, Chung JY, Cho H, Ylaya K, Hong SM, Moskaluk CA, Hewitt SM.

J Transl Med. 2011 Jul 29;9:126. doi: 10.1186/1479-5876-9-126.

16.

Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.

Liu Z, Zhang X, Huang D, Liu Y, Zhang X, Liu L, Li G, Dai Y, Tan H, Xiao J, Tian Y.

Med Oncol. 2012 Dec;29(5):3381-8. doi: 10.1007/s12032-012-0306-9. Epub 2012 Jul 20.

PMID:
22815155
17.

Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.

Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, Herlyn M.

Clin Cancer Res. 1999 Apr;5(4):775-82.

18.

ADAM8 in squamous cell carcinoma of the head and neck: a retrospective study.

Zielinski V, Brunner M, Heiduschka G, Schneider S, Seemann R, Erovic B, Thurnher D.

BMC Cancer. 2012 Feb 27;12:76. doi: 10.1186/1471-2407-12-76.

19.

CCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma.

Feng Z, Guo W, Zhang C, Xu Q, Zhang P, Sun J, Zhu H, Wang Z, Li J, Wang L, Wang B, Ren G, Ji T, Tu W, Yang X, Qiu W, Mao L, Zhang Z, Chen W.

PLoS One. 2011;6(10):e26399. doi: 10.1371/journal.pone.0026399. Epub 2011 Oct 31.

20.

Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.

Sepiashvili L, Hui A, Ignatchenko V, Shi W, Su S, Xu W, Huang SH, O'Sullivan B, Waldron J, Irish JC, Perez-Ordonez B, Liu FF, Kislinger T.

Mol Cell Proteomics. 2012 Nov;11(11):1404-15. doi: 10.1074/mcp.M112.020933. Epub 2012 Aug 23.

Supplemental Content

Support Center